Your browser doesn't support javascript.
loading
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
Jarrett, Jennie B; Bratberg, Jeffrey; Burns, Anne L; Cochran, Gerald; DiPaula, Bethany A; Legreid Dopp, Anna; Elmes, Abigail; Green, Traci C; Hill, Lucas G; Homsted, Felicity; Hsia, Stephanie L; Matthews, Michele L; Ghitza, Udi E; Wu, Li-Tzy; Bart, Gavin.
Afiliación
  • Jarrett JB; Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, USA.
  • Bratberg J; Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
  • Burns AL; American Pharmacists Association, Washington, DC, USA (retired).
  • Cochran G; Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA.
  • DiPaula BA; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA.
  • Legreid Dopp A; American Society of Health-System Pharmacists, Washington, DC, USA.
  • Elmes A; Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, USA.
  • Green TC; COBER on Opioids and Overdose at Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Hill LG; Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.
  • Homsted F; The University of Texas at Austin, College of Pharmacy, Austin, TX, USA.
  • Hsia SL; FQHC 340B Compliance, Inc., Lebanon, TN, USA.
  • Matthews ML; Department of Clinical Pharmacy, San Francisco School of Pharmacy, University of California, San Francisco, CA, USA.
  • Ghitza UE; Department of Pharmacy Practice, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
  • Wu LT; National Institute on Drug Abuse (NIDA), Center for the Clinical Trials Network (CCTN), Bethesda, MD, USA.
  • Bart G; Duke University School of Medicine, Durham, NC, USA.
Subst Abus ; 44(4): 264-276, 2023 10.
Article en En | MEDLINE | ID: mdl-37902032

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacias / Farmacia / Buprenorfina / Trastornos Relacionados con Opioides Límite: Humans Idioma: En Revista: Subst Abus Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacias / Farmacia / Buprenorfina / Trastornos Relacionados con Opioides Límite: Humans Idioma: En Revista: Subst Abus Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos